Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - Americas

Americas

Revenue in the Diabetes Care Devices market market in the Americas is projected to reach US$13.96bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 11.71%, resulting in a market volume of US$24.29bn by 2029.
In a global comparison, the majority of this revenue will be generated the United States, which is anticipated to reach US$11,710.00m in 2024.
The United States is witnessing a significant shift towards innovative diabetes care devices, driven by increasing consumer demand for personalized health management solutions.

Key regions: Netherlands, Japan, France, Italy, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Diabetes Care Devices Market in the Americas is experiencing considerable growth, fueled by increasing prevalence of diabetes, advancements in technology, and heightened awareness of diabetes management among patients, leading to greater demand for innovative solutions.

Customer preferences: Consumers in the Americas are increasingly prioritizing personalized diabetes management solutions, leading to a rise in demand for smart glucose monitors and insulin delivery systems that integrate with mobile apps. This trend is driven by a growing emphasis on data-driven health management and a desire for more user-friendly, customizable devices. Additionally, the aging population and increased health consciousness among younger demographics are influencing preferences towards advanced technology that facilitates proactive diabetes care and enhances overall quality of life.

Trends in the market: In the Americas, the Diabetes Care Devices Market is experiencing a significant shift towards integrated digital health solutions, as consumers increasingly seek devices that offer real-time data tracking and personalized insights. Smart glucose monitors equipped with mobile app connectivity are becoming mainstream, enabling users to monitor their glucose levels effortlessly while receiving tailored recommendations. Furthermore, the adoption of automated insulin delivery systems is on the rise, supported by advancements in technology and a focus on improving patient outcomes. This trend is crucial for industry stakeholders, as it signals the need for innovation and collaboration in product development to meet the evolving demands of a more health-conscious population.

Local special circumstances: In the Americas, the Diabetes Care Devices Market is shaped by diverse geographical and cultural factors that influence consumer behavior and regulatory frameworks. In the United States, for instance, a strong emphasis on preventive care and chronic disease management drives demand for advanced diabetes technologies, including continuous glucose monitors (CGMs) and insulin pumps. Meanwhile, in Canada, public health initiatives promote awareness and accessibility of diabetes care, encouraging adoption of integrated health solutions. Additionally, varying reimbursement policies across states and provinces impact market dynamics, shaping how companies approach product development and distribution strategies.

Underlying macroeconomic factors: The Diabetes Care Devices Market in the Americas is significantly influenced by macroeconomic factors such as national economic health, healthcare spending, and demographic trends. In the U.S., robust economic growth supports increased investments in healthcare technologies, driving demand for innovative diabetes management solutions. Fiscal policies, including funding for public health initiatives, enhance accessibility to diabetes care devices. Furthermore, the rising prevalence of diabetes, coupled with an aging population, underscores the necessity for advanced technologies. These factors collectively create a conducive environment for market expansion, shaping strategies for manufacturers and healthcare providers alike.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.